UPDATE : Friday, August 23, 2019
상단여백
Invossa still effective despite mislabeling, maker claims
Kolon Life Science said that U.S. orthopedic surgeons had published a resea...
by Lee Han-soo  |  2019-08-23 20:16
라인
Medipost’s Pneumostem gets FDA’s fast-track designation
Medipost said that the U.S. Food and Drug Administration has given a fast- ...
by Lee Han-soo  |  2019-08-23 17:51
라인
Vivozon finishes P3 trial for nonnarcotic analgesics
Vivozon, a local biopharmaceutical company, said Friday that it has complet...
by Lee Han-soo  |  2019-08-23 16:03
라인
49 international healthcare experts receive Korean medical training
Forty-nine healthcare professionals from 10 countries have come to Korea to...
by Choi Gwang-seok  |  2019-08-23 16:02
라인
'Surgery more viable option for gastroesophageal reflux disease'
A research team at Chung-Ang University Hospital (CUH) has proved that surg...
by Lee Han-soo  |  2019-08-23 15:02
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
HLB said Thursday it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
Haim Bio said that the Ministry of Food and Drug Safety has approved its in...
by Lee Han-soo  |  2019-08-23 13:53
라인
GenNBio to test transplanting pig’s pancreatic islet into human next year
GenNBio said it would officially enter the market of transplanting organs f...
by Jeong Sae-im  |  2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
Peptron said it has confirmed that PT320, a Parkinson's disease treatme...
by Lee Han-soo  |  2019-08-22 17:53
라인
Japan gives further nod to Celltrion's breast cancer biosimilar
Celltrion Healthcare said that Japan's Ministry of Health, Labour and W...
by Lee Han-soo  |  2019-08-22 16:47
라인
‘Drug firm’s pick of doctor to attend conference overseas illegal’
Pharmaceutical companies’ support for physicians to attend academic confere...
by Kim Yun-mi  |  2019-08-22 15:45
라인
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by ...
by Lee Hye-seon  |  2019-08-22 15:37
라인
Tego Science’s diabetic foot ulcer treatment gets insurance benefit
Tego Science said that Kaloderm, a homologous cell-based drug, will receive...
by Lee Han-soo  |  2019-08-22 15:34
라인
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment
Daewoong Pharmaceutical said that it has won the go-ahead for its phase 1 c...
by Lee Han-soo  |  2019-08-22 14:36
라인
GE Healthcare offers new era of hospital management with ‘command center’
As populations are aging globally, especially among developed nations, hosp...
by Lee Han-soo  |  2019-08-22 14:36
라인
Cloud-based system to turn dispersed medical information into big data
Korean hospitals have completed building a pilot cloud-based system to coll...
by Song Soo-youn  |  2019-08-22 13:52
라인
K-Hospital Fair 2019 opens 3-day show in Seoul
The K-Hospital Fair 2019 kicked off its three-day run in Seoul Wednesday. ...
by Lee Han-soo  |  2019-08-21 23:36
라인
Chong Kun Dang invests ￦5 billion in Biorchestra
Chong Kun Dang Holdings said that would invest 5 billion won ($4.1 million)...
by Lee Han-soo  |  2019-08-21 16:42
라인
‘Untreated sleep apnea can reduce brain function, damage brain tissue’
A research team at Seoul National University Bundang Hospital has discovere...
by Lee Han-soo  |  2019-08-21 16:42
라인
'Patient safety threatened despite technological advance'
Korean hospitals should introduce the right digital solution, as they might...
by Lee Han-soo  |  2019-08-21 16:41
-12345678910-
Invossa still effective despite mislabeling, maker claimsInvossa still effective despite mislabeling, maker claims
여백
Most viewed
여백
Opinion
[Reporter’s Notebook] SillaJen should be ashamed of itself
[Reporter’s Notebook] SillaJen should be ashamed of itself
[Column] Drug regulator needs adequate expertise to promote medical devices
[Column] Drug regulator needs adequate expertise to promote medical devices
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
[Reporter's Notebook] Korean drugmakers should increase presence at global conventions
여백
Back to Top